SLAYBACK PHARMA LLC FDA Approval ANDA 211304

ANDA 211304

SLAYBACK PHARMA LLC

FDA Drug Application

Application #211304

Documents

Letter2021-09-02

Application Sponsors

ANDA 211304SLAYBACK PHARMA LLC

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 10MG BASE/ML0METARAMINOL BITARTRATEMETARAMINOL BITARTRATE

FDA Submissions

UNKNOWN; ORIG1AP2021-08-24STANDARD

Submissions Property Types

ORIG1Null15

CDER Filings

SLAYBACK PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211304
            [companyName] => SLAYBACK PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"METARAMINOL BITARTRATE","activeIngredients":"METARAMINOL BITARTRATE","strength":"EQ 10MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/24\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-08-24
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.